Want to see RARE full AI Analyst Report?
Ultragenyx Pharmaceutical (RARE) Ownership Overview
3.95% Insiders
19.35% Mutual Funds
39.44% Other Institutional Investors
21.35% ETFs
15.91% Public Companies and Individual Investors
The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail, and individual investors. Approximately 80.14% of the company’s stock is owned by Institutional Investors, 3.95% is owned by Insiders, and 15.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 15, 2026 | xxxxxxxxxxxxx | $17410 | |
Sep 08, 2026 | xxxxxxxxxxxxx | $2252 | |
Aug 04, 2026 | xxxxxxxxxxxxx | $47348 | |
Aug 04, 2026 | xxxxxxxxxxxxx | $117024 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $105457908 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $4275089 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $860327 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,482,304 | Institution | 8.60% | 126,216,684 | |
| 7,319,932 | Institution | 7.42% | 108,920,588 | |
| 5,644,100 | Institution | 5.72% | 83,984,208 | |
| 4,592,489 | Institution | 4.66% | 68,336,236 | |
| 3,158,368 | Institution | 3.20% | 46,996,516 | |
| 2,894,724 | Insider | 2.94% | 43,073,493 | |
| 2,772,692 | Institution | 2.81% | 41,257,657 | |
| 1,906,644 | Institution | 1.93% | 28,370,863 | |
| 1,062,189 | Institution | 1.08% | 15,805,372 | |
| 1,019,400 | Institution | 1.03% | 15,168,672 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,319,932 | Institution | 7.42% | 108,920,588 | |
| 1,906,644 | Institution | 1.93% | 28,370,863 | |
| 1,062,189 | Institution | 1.08% | 15,805,372 | |
| 1,019,400 | Institution | 1.03% | 15,168,672 | |
| 889,257 | Institution | 0.90% | 13,232,144 | |
| 650,491 | Institution | 0.66% | 9,679,306 | |
| 612,681 | Institution | 0.62% | 9,116,693 | |
| 577,974 | Institution | 0.59% | 8,600,253 | |
| 437,896 | Institution | 0.44% | 6,515,892 | |
| 436,003 | Institution | 0.44% | 6,487,725 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,291,978 | Institution | 5.37% | 82,634,236 | |
| 2,996,552 | Institution | 3.04% | 75,543,076 | |
| 2,475,343 | Institution | 2.51% | 36,833,104 | |
| 2,151,354 | Institution | 2.18% | 54,235,634 | |
| 1,232,493 | Institution | 1.25% | 31,071,149 | |
| 1,146,994 | Institution | 1.16% | 28,915,719 | |
| 678,265 | Institution | 0.69% | 10,092,583 | |
| 555,783 | Institution | 0.56% | 14,011,289 | |
| 520,778 | Institution | 0.53% | 8,131,948 | |
| 496,998 | Institution | 0.50% | 7,395,330 |
FAQ
Who Owns Ultragenyx Pharmaceutical (RARE)?
According to the latest TipRanks data, approximately 39.44% of the company's stock is held by institutional investors, 3.95% is held by insiders, and 15.91% is held by retail investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.44% of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors?
According to the latest TipRanks data, approximately 15.91% of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors.
Who owns the most shares of Ultragenyx Pharmaceutical (RARE)?
Vanguard owns the most shares of Ultragenyx Pharmaceutical (RARE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.